Ajanta Pharma Q3 Results: Net Profit Up 11% At Rs 233 Crore

Ajanta Pharma on Thursday said its consolidated profit after tax increased by 11% on-year to Rs 233 crore for the third quarter ended Dec. 31, 2024. The drug firm had reported a profit of Rs 210 crore in the October-December period of last fiscal.

Revenue from operations stood at Rs 1,146 crore in the third quarter compared to Rs 1,105 crore in the year-ago period, Ajanta Pharma said in a regulatory filing.

Shares of the company settled 1.64 per cent higher at Rs 2,670.70 apiece on the BSE.